Lawson Lundell Advises Molecular You in Securing USD$5 Million Series A Financing to Scale its Predictive Health Platform
Lawson Lundell is pleased to have advised Molecular You in the closing of its USD$5 million Series A round led by Voloridge Health. This is a significant milestone for Molecular You as the funding will allow the company to expand its cutting-edge predictive health platform and accelerate its mission to move healthcare from reactive to predictive and preventive by scaling the company’s multi‑omic blood test that analyzes 250+ biomarkers across 25+ health areas from a single tube of blood.
Garrett Lee acted as lead legal advisor to Molecular You on this financing, with support from Austin Darling.
Headquartered in Vancouver, British Columbia, Molecular You measures over 250 biomarkers with a single blood test using advanced proteomics and metabolomics to identify health risks at their root cause. Its AI-powered platform delivers personalized assessments and insights, along with actionable recommendations for over 25 health areas, to support longevity, chronic disease management, and early disease prevention.
Voloridge Health is a data science-driven company that invests in innovative companies and pioneering health technologies that can leverage Voloridge's expertise in data science to accelerate their growth by combining resources, knowledge, and networks to drive advancements.
About Lawson Lundell
Lawson Lundell LLP is a Western Canadian based business law firm driven by our desire to offer clients a practical and strategic approach to solving their legal and business problems. The firm's diverse and globally connected client base provides opportunities in Canada and around the world allowing us to stay current on changes and developments worldwide. Connect with our lawyers today: inquiries@lawsonlundell.com